From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis

DOI: 10.5306/wjco.v8.i1.37

Keywords: Immune checkpoint inhibitors, PD-1, PD-L1, Checkpoint inhibitors, Cancer treatment, Immune checkpoint blockade, Anti-PD-1 antibodies, Anti-PD-L1 antibodies

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text